Results 1 to 10 of about 28,976,802 (355)

Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine. [PDF]

open access: yes, 2018
Whether γδ T cells inhibit or enhance the Foxp3 T cell response depends upon their activation status. The critical enhancing effector in the supernatant is adenosine.
Born, Willi K   +6 more
core   +15 more sources

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy

open access: yesJournal of Animal Reproduction and Biotechnology, 2022
Currently, there is no treatment to reverse or cure heart failure caused by ischemic heart disease and myocardial infarction despite the remarkable advances in modern medicine.
Yun-Gwi Park   +3 more
doaj   +1 more source

CAR-T cell therapy: current limitations and potential strategies

open access: yesBlood Cancer Journal, 2021
Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses with certain subsets of B cell leukemia or lymphoma, many challenges limit ...
Robert C. Sterner, Rosalie M. Sterner
semanticscholar   +1 more source

Novel microRNAs modulating ecto-5′-nucleotidase expression

open access: yesFrontiers in Immunology, 2023
IntroductionThe expression of immune checkpoint molecules (ICMs) by cancer cells is known to counteract tumor-reactive immune responses, thereby promoting tumor immune escape.
Theresa Kordaß   +4 more
doaj   +1 more source

Long-term outcomes following CAR T cell therapy: what we know so far

open access: yesNature Reviews Clinical Oncology, 2023
Chimeric antigen receptors (CAR) are engineered fusion proteins designed to target T cells to antigens expressed on cancer cells. CAR T cells are now an established treatment for patients with relapsed and/or refractory B cell lymphomas, B cell acute ...
Kathryn M. Cappell, J. Kochenderfer
semanticscholar   +1 more source

A guide to cancer immunotherapy: from T cell basic science to clinical practice

open access: yesNature reviews. Immunology, 2020
The T lymphocyte, especially its capacity for antigen-directed cytotoxicity, has become a central focus for engaging the immune system in the fight against cancer.
A. Waldman, Jill M. Fritz, M. Lenardo
semanticscholar   +1 more source

Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC

open access: yesScientific Reports, 2022
The differentiation of pancreatic endocrine cells from human pluripotent stem cells has been thoroughly investigated for their application in cell therapy against diabetes.
Hideyuki Hiyoshi   +10 more
doaj   +1 more source

Recent advances in edible coating of food products and its legislations: A review

open access: yesJournal of Agriculture and Food Research, 2023
Food products are highly perishable in nature which undergoes quick quality deterioration. In this note, the kind of packaging decides the active preservation of food qualities.
Krishna Priya   +2 more
doaj   +1 more source

ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes

open access: yesNature Communications, 2021
Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) suffer from limited maturation. Here the authors identify ERRγ agonist as a factor that enhances cardiac morphological, metabolic, contractile and electrical maturation of ...
Kenji Miki   +20 more
doaj   +1 more source

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

open access: yesNature Communications, 2021
T-cell immunotherapies, such as CAR-T immunotherapy, are being developed against a wide variety of diseases. Here the authors report the feeder-free, scalable differentiation of human induced pluripotent cells (iPSCs) to T-cells with T-cell receptor ...
Shoichi Iriguchi   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy